Your browser doesn't support javascript.
loading
Daratumumab plus lenalidomide and dexamethasone in transplant-ineligible newly diagnosed multiple myeloma: frailty subgroup analysis of MAIA.
Facon, Thierry; Cook, Gordon; Usmani, Saad Z; Hulin, Cyrille; Kumar, Shaji; Plesner, Torben; Touzeau, Cyrille; Bahlis, Nizar J; Basu, Supratik; Nahi, Hareth; Goldschmidt, Hartmut; Quach, Hang; Mohty, Mohamad; Venner, Christopher P; Weisel, Katja; Raje, Noopur; Hebraud, Benjamin; Belhadj-Merzoug, Karim; Benboubker, Lotfi; Decaux, Olivier; Manier, Salomon; Caillot, Denis; Ukropec, Jon; Pei, Huiling; Van Rampelbergh, Rian; Uhlar, Clarissa M; Kobos, Rachel; Zweegman, Sonja.
Afiliación
  • Facon T; University of Lille, CHU Lille, Service des Maladies du Sang, Lille, France. thierry.facon@chru-lille.fr.
  • Cook G; Leeds Cancer Centre, Leeds Teaching Hospitals Trust, Leeds, UK.
  • Usmani SZ; Levine Cancer Institute/Atrium Health, Charlotte, NC, USA.
  • Hulin C; Department of Hematology, Hôpital Haut Lévêque, University Hospital, Pessac, France.
  • Kumar S; Department of Hematology, Mayo Clinic Rochester, Rochester, MN, USA.
  • Plesner T; Vejle Hospital and University of Southern Denmark, Vejle, Denmark.
  • Touzeau C; Centre Hospitalier Universitaire, Nantes, France.
  • Bahlis NJ; University of Calgary, Arnie Charbonneau Cancer Research Institute, Calgary, AB, Canada.
  • Basu S; The Royal Wolverhampton Hospitals NHS Trust, University of Wolverhampton, Wolverhampton, UK.
  • Nahi H; Karolinska Institute, Department of Medicine, Division of Hematology, Karolinska University Hospital at Huddinge, Stockholm, Sweden.
  • Goldschmidt H; University Clinic Heidelberg, International Medicine V and National Center of Tumor Diseases (NCT), Heidelberg, Germany.
  • Quach H; University of Melbourne, St. Vincent's Hospital, Melbourne, VIC, Australia.
  • Mohty M; Sorbonne University, Department of Hematology, Saint-Antoine Hospital, Paris, France.
  • Venner CP; Cross Cancer Institute, University of Alberta, Edmonton, AB, Canada.
  • Weisel K; Department of Oncology, Hematology and Bone Marrow Transplantation With Section of Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Raje N; Department of Hematology/Oncology, Massachusetts General Hospital, Boston, MA, USA.
  • Hebraud B; Institut Universitaire du Cancer and University Hospital, Toulouse, France.
  • Belhadj-Merzoug K; Hémopathies Lymphoïdes, Hôpital Henri Mondor, Créteil, France.
  • Benboubker L; CHRU de Tours, Hôpital de Bretonneau, Tours, France.
  • Decaux O; Clinical Haematology Department, University of Rennes, CHU Rennes, CIC INSERM 1414, Rennes, France.
  • Manier S; University of Lille, CHU Lille, Service des Maladies du Sang, Lille, France.
  • Caillot D; CHU Dijon, Hôpital du Bocage, Dijon, France.
  • Ukropec J; Janssen Global Medical Affairs, Horsham, PA, USA.
  • Pei H; Janssen Research & Development, LLC, Titusville, NJ, USA.
  • Van Rampelbergh R; Janssen Research & Development, Beerse, Belgium.
  • Uhlar CM; Janssen Research & Development, LLC, Spring House, PA, USA.
  • Kobos R; Janssen Research & Development, LLC, Raritan, NJ, USA.
  • Zweegman S; Department of Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, The Netherlands.
Leukemia ; 36(4): 1066-1077, 2022 04.
Article en En | MEDLINE | ID: mdl-34974527

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Fragilidad / Mieloma Múltiple Tipo de estudio: Diagnostic_studies / Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Leukemia Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2022 Tipo del documento: Article País de afiliación: Francia

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Fragilidad / Mieloma Múltiple Tipo de estudio: Diagnostic_studies / Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Leukemia Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2022 Tipo del documento: Article País de afiliación: Francia